The Gene Therapy Market Revenue was valued at USD 9.2 billion in 2023 and is projected to reach a staggering USD 54.39 billion by 2032, expanding at a robust CAGR of 23.12% during the forecast period. The market’s rapid growth is fueled by significant advancements in biotechnology, rising demand for personalized medicine, and increasing investments in innovative gene-based treatments to address ..